Aprea Therapeutics, Inc. Common stock APRE
$0.68
+1.33%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $3.07
- Implied Upside
- +351.0%
- Price Target Range
- $1.20 – $5.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-13 | WedbushRobert Driscoll |
Maintains | Outperform | $6 → $3 |
| 2026-05-14 | WedbushRobert Driscoll |
Maintains | Outperform | $7 → $6 |
| 2026-05-07 | OppenheimerMatthew Biegler |
Initiates coverage on | Outperform | $5 |
| 2026-03-31 | WedbushRobert Driscoll |
Reiterates | Outperform | $7 |
| 2026-03-31 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $4 → $1 |
| 2026-02-10 | WedbushRobert Driscoll |
Maintains | Outperform | $11 → $7 |
| 2026-01-29 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $5 → $4 |
| 2025-12-18 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $20 → $5 |
| 2025-01-15 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2024-12-17 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2024-11-18 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2024-10-24 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2024-08-13 | WedbushRobert Driscoll |
Reiterates | Outperform | $11 |
| 2024-08-12 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2024-06-24 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2024-06-17 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2024-05-14 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2024-03-27 | WedbushRobert Driscoll |
Maintains | Outperform | $9 → $11 |
| 2024-03-26 | HC Wainwright & Co.Joseph Pantginis |
Maintains | Buy | $20 |
| 2023-11-01 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2023-09-13 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2023-08-10 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2023-05-16 | HC Wainwright & Co.Joseph Pantginis |
Reiterates | Buy | $20 |
| 2023-03-10 | Maxim GroupJason McCarthy |
Initiates coverage on | Buy | $16 |
| 2022-10-10 | HC Wainwright & Co.Joseph Pantginis |
Assumes | Buy | $60 |
| 2022-07-08 | WedbushRobert Driscoll |
Initiates coverage on | Outperform | $60 |
| 2022-03-16 | HC Wainwright & Co.Andrew Fein |
Maintains | Neutral | $80 → $40 |
| 2022-03-16 | RBC CapitalGregory Renza |
Maintains | Sector perform | $100 → $80 |
| 2021-08-20 | JP MorganJessica Fye |
Downgrades | Neutral → Underweight | — |
| 2021-08-16 | BerenbergEsther Hong |
Downgrades | Buy → Hold | — |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $0.68
- Market Cap
- $8.46 million
- 52-Week Range
- $0.55 – $2.22
- Average Volume
- 50K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.